Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This is an image advertising a webinar called BioCentury and BIA present: Company building in a COVID-19 world.

As the COVID-19 crisis continues, how has the U.K.’s biotech ecosystem fared?

  • How much cash runway do companies have?
  • Will management teams secure their target levels of financing?
  • Are U.K. biotechs taking advantage of new government support packages, including the Future Fund and the Coronavirus Job Retention Scheme?

Following the discussion, BioCentury and BIA convene a special panel of U.K biotech CEOs and investors to discuss the survey, and the outlook for company building in a COVID-19 world. 



Simone Fishburn, Ph.D., VP & Editor in Chief, BioCentury Inc

Steve Bates, CEO, UK BioIndustry Association

Charlotte Casebourne - CEO, Theolytics

Jolyon Martin - Head of Business Development and Co-Founder, PetMedix


To register click here